Carbapenem-sparing beta-lactam/beta-lactamase inhibitors versus carbapenems for bloodstream infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Carbapenem-sparing beta-lactam/beta-lactamase inhibitors versus carbapenems for bloodstream infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis

Published:2023-03 Issue: Volume:128 Page:194-204
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Zhang Huan,Xu Juan,Xiao Qinyan,Wang Yuhang,Wang Jin,Zhu Man,Cai Yun

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference54 articles.

1. Combination therapy with aminoglycoside in Bacteremiasdue to ESBL-producing Enterobacteriaceae in ICU;Benetazzo;Antibiotics (Basel),2020

2. β-lactamases and β-lactamase Inhibitors in the 21st Century;Tooke;J Mol Biol,2019

3. High prevalence and characterization of extended-spectrum ß-lactamase producing Enterobacteriaceae in Chadian hospitals;Ouchar Mahamat;BMC Infect Dis,2019

4. Infectious Diseases Society of America. IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections: Version 1.0, https://www.idsociety.org/practice-guideline/amr-guidance/; 2022 [accessed 22 December 2022].

5. Carbapenem-sparing strategies for ESBL Producers: When and How;Karaiskos;Antibiotics (Basel),2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Piperacillin-tazobactam vs. carbapenems for treating hospitalized patients with ESBL-producing Enterobacterales bloodstream infections: A systematic review and meta-analysis;Journal of Global Antimicrobial Resistance;2024-12

2. Carbapenem use in extended-spectrum cephalosporin-resistant Enterobacterales infections in US hospitals and influence of IDSA guidance: a retrospective cohort study;The Lancet Infectious Diseases;2024-08

3. Clinical Characteristics, Prognosis and Treatment of Bloodstream Infections with Enterobacter Cloacae Complex in a Chinese Tertiary Hospital: A Retrospective Study;Infection and Drug Resistance;2024-05

4. Epidemiology, Clinical, and Microbiological Characteristics of Multidrug-Resistant Gram-Negative Bacteremia in Qatar;Antibiotics;2024-03-31

5. Effectiveness of empiric carbapenem versus non-carbapenem therapy for extended-spectrum β-lactamase producing Enterobacterales infections in non-intensive care unit patients: a real-world investigation in a hospital with high-prevalence of extended-spectrum β-lactamase producing Enterobacterales;Antimicrobial Stewardship & Healthcare Epidemiology;2024